Search - tctmd.com

Displaying 1 - 20 of 20

Sort: Relevancy | Date

News Daily News

A Tight Spot: Drug-Eluting Stents Seem to Top Other Options for Small-Vessel Disease

Todd Neale

June 16, 2016

News Daily News

COMPARE:5 年时 EES 的疗效仍优于 PES

Salynn Boyles

July 30, 2015

News Daily News

COMPARE: Los EES siguen siendo Superiores a los SLP a los 5 Años

Salynn Boyles

July 30, 2015

News Daily News

COMPARE: EES Maintains Advantage Over PES at 5 Years

Salynn Boyles

July 30, 2015

News Daily News

Postdilation May Improve Outcomes After Self-Expanding Stent Is Used in Primary PCI

L.A. McKeown

March 18, 2015

News Daily News

La Postdilatación podría Mejorar los Resultados Post-Implantación de Stents Auto Expandibles en PCI Primarias

L.A. McKeown

March 18, 2015

News Daily News

TCTMD’s Top 10 Most Popular News Stories for 2014

Caitlin E. Cox

January 12, 2015

News Daily News

Retrasar la Cirugía No Cardíaca durante 6 Meses tras la Implantación de un Stent Coronario podría Reducir las Complicaciones

L.A. McKeown

January 12, 2015

News Daily News

Delaying Noncardiac Surgery for 6 Months After Coronary Stenting May Reduce Complications

L.A. McKeown

January 12, 2015

News Daily News

More Long-term Cardiac Mortality with First-Generation DES vs. BMS for STEMI

July 24, 2013

News Daily News

Mayor mortalidad cardíaca a largo plazo con la primera generación de SLF vs. SMD para STEMI

July 24, 2013

News Daily News

HORIZONS-AMI: La Bivalirudina y Taxus Mejoran los Resultados en Pacientes sometidos a una PCI en la Arteria Descendente Anterior Izda

Leah Lawrence

July 11, 2013

News Daily News

HORIZONS-AMI: Bivalirudin, Taxus Improve Outcomes in LAD PCI Patients

Leah Lawrence

July 11, 2013

Presentation

Impact of Bivalirudin and Paclitaxel-Eluting Stents on Outcomes in Patients Undergoing Primary PCI of the LAD

Presenter: Jochen W?hrle

July 09, 2013

News Daily News

Meta-Analysis: First-Gen DES Show Long-term Safety, Efficacy in STEMI Setting

L.A. McKeown

April 25, 2012

News Daily News

Meta Análisis: Los SLF de 1ª Generación se Muestran Seguros y Eficaces a Largo Plazo contra los STEMI

L.A. McKeown

April 25, 2012

News Daily News

HORIZONS-AMI: CKD Patients Fare Poorly Regardless of Stent Type, Antithrombotic Regimen

Leah Lawrence

September 29, 2011

News Conference News

Two Trials Show Favorable Results with XIENCE V vs. Earlier DES, BMS

September 02, 2011

News Daily News

HORIZONS-AMI Published: Bivalirudin, Taxus Stay Strong at 3 Years

Jason Kahn

June 13, 2011

News Daily News

PES Show Delayed Healing in STEMI Patients, Clinical Significance Downplayed

Jason Kahn

January 12, 2011

Advertisement

A Tight Spot: Drug-Eluting Stents Seem to Top Other Options for Small-Vessel Disease

COMPARE:5 年时 EES 的疗效仍优于 PES

COMPARE: Los EES siguen siendo Superiores a los SLP a los 5 Años

COMPARE: EES Maintains Advantage Over PES at 5 Years

Postdilation May Improve Outcomes After Self-Expanding Stent Is Used in Primary PCI

La Postdilatación podría Mejorar los Resultados Post-Implantación de Stents Auto Expandibles en PCI Primarias

TCTMD’s Top 10 Most Popular News Stories for 2014

Retrasar la Cirugía No Cardíaca durante 6 Meses tras la Implantación de un Stent Coronario podría Reducir las Complicaciones

Delaying Noncardiac Surgery for 6 Months After Coronary Stenting May Reduce Complications

More Long-term Cardiac Mortality with First-Generation DES vs. BMS for STEMI

Mayor mortalidad cardíaca a largo plazo con la primera generación de SLF vs. SMD para STEMI

HORIZONS-AMI: La Bivalirudina y Taxus Mejoran los Resultados en Pacientes sometidos a una PCI en la Arteria Descendente Anterior Izda

HORIZONS-AMI: Bivalirudin, Taxus Improve Outcomes in LAD PCI Patients

Impact of Bivalirudin and Paclitaxel-Eluting Stents on Outcomes in Patients Undergoing Primary PCI of the LAD

Meta-Analysis: First-Gen DES Show Long-term Safety, Efficacy in STEMI Setting

Meta Análisis: Los SLF de 1ª Generación se Muestran Seguros y Eficaces a Largo Plazo contra los STEMI

HORIZONS-AMI: CKD Patients Fare Poorly Regardless of Stent Type, Antithrombotic Regimen

Two Trials Show Favorable Results with XIENCE V vs. Earlier DES, BMS

HORIZONS-AMI Published: Bivalirudin, Taxus Stay Strong at 3 Years

PES Show Delayed Healing in STEMI Patients, Clinical Significance Downplayed

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content